Cellular Goods files patent for cannabinoid skin innovation

Cellular Goods has filed its first patent application for a cannabinoid-based skin brightening solution.

The UK-based wellness company that provides consumer products formulated with lab-made cannabinoids, has announced the filing of its first patent application, related to the use of cannabinoids for skin brightening. 

Internal and external factors like hormonal changes during pregnancy and exposure to the sun can cause skin conditions such as melasma and hyperpigmentation that can make the skin tone change and become uneven. 

Within the cosmetics and beauty industry, a number of products have been developed  to help people achieve an even and brighter skin tone.  

Most products in the market rely primarily on active ingredients such as Vitamin C,  exfoliating acids and hydroquinones that while effective in tackling melasma and hyperpigmentation,  can cause skin irritation and sensitivity. 

This has created a need for new ingredients that are equally  effective as the components in traditional skin brightening products, but that don’t produce the uncomfortable side effects and have better tolerability for frequent use. 

Cellular Goods conducted scientific research to assess the potential of cannabinoids as skin brightening ingredients. 

The series of research, which involved in-vitro human tissue models, a well-established method for assessing the effectiveness of skin brightening ingredients, found that lab-made cannabinoids, namely cannabigerol (CBG), can improve the effectiveness of  certain active ingredients used in traditional skin brightening products. 

These findings provide the basis for a new class of skin brightening solutions that can improve skin tone evenness associated with various  factors, such as melasma and hyperpigmentation. 

This application is the first patent filed by the company and is anticipated to form part of a wider patent portfolio driven by Cellular Goods’ research into the wellness benefits of lab-made cannabinoids.  

The company has been using research to offer customers innovative products such as its Rejuvenating Cannabinoid Face Serum, the UK’s first CBG-based serum to prevent the signs of ageing caused by UV light exposure and inflammation.

Anna Chokina, CEO of Cellular Goods, said: “From having skin brightening properties, through to helping prevent the signs of ageing caused by UV light exposure and inflammation, cannabinoids have a number of skincare benefits that we are only just starting to understand. The filing of this patent based  on our own research is part of our efforts to help unveil the benefits of cannabinoids, as well as to  develop science-backed innovations that can improve people’s wellness. 

“We look forward to  contributing to the growing body of research on cannabinoids, particularly their skincare benefits, while  also growing our patent portfolio.” 

Alexia Blake, head of research and product development added: “We are proud  to be developing the body of research on the skin brightening qualities of cannabinoids with the  completion of our research and the filing of this patent. 

“This work builds on our existing research involving lab-made cannabinoids, including the publication of a white paper on the potential benefits  that cannabinoids can have for the skin by preventing the signs of ageing caused by UV exposure and  inflammation. We are committed to continuing to develop research that will help us better understand the unique benefits of cannabinoids and how to effectively leverage these benefits across our product  offerings.” 

For more industry news visit Cannabis Wealth

• David Beckham-backed CBG skincare line launches new products
• CBD and CBG show potential for fighting signs of ageing
• Clint Eastwood wins $6m in damages from CBD company in lawsuit
• The role of technology in cannabis
• Provacan launches enhanced terpene formulation in UK market